Hypertrophic Cardiomyopathy Medical Society

07/09/2025

If you have a late-breaking abstract for our HCMS@AHA Scientific Sessions, never fear. There’s still time to submit it.

But don’t delay! The deadline for both the late-breaking Science submissions and late-breaking BASIC Science Submissions is 7 pm EDT on Aug. 4.

The AHA Professional Member submission fee is $45 and the non-member submission fee is $95. You can find the guidelines for both BASIC Science and Science submissions, and upload your submissions here: http://bit.ly/4lAvkme

07/08/2025

Do you have a late-breaking abstract for our HCMS@AHA Scientific Sessions? There's still time to submit it! But don't delay. Submit your late-breaking abstract by Aug. 4 here: http://bit.ly/4lAvkme

07/02/2025

Registration is open for the HCMS Scientific Sessions in New Orleans Nov. 7-10. The 2025 Scientific Sessions are held in collaboration with the American Heart Association.

Register here: https://bit.ly/4lyEwYb

We look forward to seeing you in New Orleans this fall!

06/04/2025

HCM Society can’t wait to host our 2025 Scientific Sessions on Nov. 7 in New Orleans in conjunction with the American Heart Association’s 2025 Scientific Sessions.

Join the Society today! HCMS active members will receive a promo code allowing you to attend the one-day program free! Here’s how to join: https://hcmsociety.org/members.

Registration for both HCMS sessions and the AHA sessions opens on 6/17/25.
If you want to present, there’s still time to submit your abstract. But hurry! The deadline for submitting HCMS and AHA abstracts is June 5. https://bit.ly/4kOdnQH

Key dates:
✅June 5: Abstract submission deadline
✅June 17: HCMS & AHA Scientific Sessions registration opens
✅Nov. 7: HCMS Scientific Sessions
✅Nov. 8-10: AHA Scientific Sessions

05/30/2025

COMING SOON! The deadline for submitting an abstract to
present at our 2025 Scientific Sessions is June 5.

We invite you to submit your abstracts via the AHA’s Scientific Sessions 2025 portal at https://hcmsociety.org/2025_abstracts

Simply select the option to submit to HCMS. The categories are: Basic, Clinical and Late-breaking/Feature Science.

It's an opportunity you don’t want to miss!

05/19/2025

Have you submitted your abstract to present at our 2025 Scientific Sessions? The abstract deadline is June 5 and we could not be more excited.

We invite you to submit your abstracts via the AHA’s Scientific Sessions 2025 portal at https://hcmsociety.org/2025_abstracts

Simply select the option to submit to HCMS. The categories are: Basic, Clinical and Late-breaking/Feature Science.

Why should you present?

🩺 Share your knowledge and your important research
🩺 Build professional relationships
🩺 Contribute to advancements in early diagnosis
🩺 Give back to the profession

Submit your abstract today -- It's an opportunity you don’t want to miss!

03/02/2025

The latest episode of In the Thick Of It, "Seeing HCM Clearly: Optimizing Echocardiography for Better Diagnosis” has been published!

Description: How can echocardiographers improve the accuracy and confidence of hypertrophic cardiomyopathy diagnosis?

Sonographers Amy Dillenbeck and Brad Mehl explore the essential role of echocardiography in evaluating HCM, sharing best practices for optimizing imaging techniques, Doppler assessment, and contrast use. They discuss the most common challenges in detecting HCM, how to train sonographers to recognize subtle diagnostic clues, and strategies to avoid misinterpretation.

Whether you're a seasoned clinician or new to HCM imaging, this episode offers valuable insights into refining echocardiographic evaluation for better patient outcomes.

You can listen on any podcast platform: https://bit.ly/41BoIwC

Or view it on YouTube: https://bit.ly/4bnQ5xr

Visit our website for information about the HCMSociety and our programs at the link in our comments below.

How can echocardiographers improve the accuracy and confidence of hypertrophic cardiomyopathy diagnosis? In this episode of In the Thick of It, Dr. Amy Dille...

02/26/2025

HCM Medical Society enters collaboration to present our 2025 Scientific Sessions at AHA’s Scientific Sessions 2025, November 7-10 in New Orleans, LA.

02/25/2025

HCMS Podcast Episode 23

Understanding NSVT: Risk Assessment and ICD Decisions in HCM

How do we determine which hypertrophic cardiomyopathy patients are at the highest risk for sudden cardiac death? In this episode of In the Thick of It, Dr. Steve Ommen and Dr. Mark Link take a deep dive into the role of non-sustained ventricular tachycardia (NSVT) in risk assessment and ICD decision-making. They discuss how age, VT duration, and other clinical factors influence risk stratification, as well as the evolving guidelines on ICD placement. The conversation also covers the latest advancements in device technology and the nuances of selecting the right ICD for each patient. Don’t miss this essential discussion on refining risk assessment and improving outcomes in HCM care.

Listen to the podcast on your favorite platform: https://bit.ly/4h268SS

Or watch the video https://bit.ly/4kbyrkC

How do we determine which hypertrophic cardiomyopathy patients are at the highest risk for sudden cardiac death? In this episode of In the Thick of It, Dr. S...

02/07/2025

How can late gadolinium enhancement (LGE) on cardiac MRI help predict sudden cardiac death risk in hypertrophic cardiomyopathy?

The latest episode of In The Thick Of It, "Imaging Matters: How LGE Guides HCM Management” has been published!

Dr. Kramer and Dr. Chan, thanks again for coming on the show!

You can listen on any podcast app https://tinyurl.com/3tbyx7sr

- or check out the video here!

01/07/2025

How has genetic testing transformed the understanding and care of hypertrophic cardiomyopathy?

Groundbreaking advancements like gene therapy, precision medicine, and the evolving understanding of variants of uncertain significance (VUS) are driving early detection, personalized therapies, and even potential cures for HCM, offer hope for patients and their families.

The latest episode of In The Thick Of It, "Cracking the Code: The Role of Genetics in HCM Diagnosis, Screening, & Treatment” has been published! You can listen on any podcast app including Spotify or Apple Podcasts. Or view this video:

01/07/2025

How has genetic testing transformed the understanding and care of hypertrophic cardiomyopathy?

Groundbreaking advancements like gene therapy, precision medicine, and the evolving understanding of variants of uncertain significance (VUS) are driving early detection, personalized therapies, and even potential cures for HCM, offer hope for patients and their families.

The latest episode of In The Thick Of It, "Cracking the Code: The Role of Genetics in HCM Diagnosis, Screening, & Treatment” has been published! You can listen on any podcast app including Spotify or Apple Podcasts. Or view this video: